| P50 | author | Hidetaka Katabuchi | Q89276961 |
| | Takeshi Motohara | Q90647896 |
| | Hironori Tashiro | Q96208959 |
| | Fumitaka Saito | Q114651579 |
| | Kiyomi Takaishi | Q114651740 |
| P2093 | author name string | Isao Sakaguchi | |
| | Toshimitsu Tohya | |
| | Hiroyuki Mimori | |
| | Saburo Shibata | |
| | Yukitoshi Fukumatsu | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial | Q28238321 |
| | A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung | Q28258014 |
| | Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer | Q28346767 |
| | Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer | Q33848566 |
| | The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents | Q34315943 |
| | Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer | Q35741367 |
| | Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer | Q36611791 |
| | Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT | Q36612324 |
| | Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. | Q40561647 |
| | Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents | Q41079432 |
| | Effect of uracil on metabolism of 5-fluorouracil in vitro | Q41735692 |
| | Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer | Q44159643 |
| | Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. | Q44374108 |
| | Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report | Q44832494 |
| | Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials | Q46412784 |
| | UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma | Q46925142 |
| | Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer | Q46941813 |
| | Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery | Q71121062 |
| | Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis | Q73061862 |
| | Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil | Q77332694 |
| | UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer | Q78111623 |
| | Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix | Q83737796 |
| P433 | issue | 3 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| P304 | page(s) | 193-200 | |
| P577 | publication date | 2015-02-17 | |
| P1433 | published in | Journal of gynecologic oncology | Q26842232 |
| P1476 | title | High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer | |
| P478 | volume | 26 | |